Abdelkader NF, Eitah HE, Maklad YA, Gamaleldin AA, Badawi MA, Kenawy SA (2020) New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats. Life Sci 247:117458. https://doi.org/10.1016/j.lfs.2020.117458

Article  CAS  PubMed  Google Scholar 

Aguirre L, Arias N, Macarulla MT, Gracia A, Portillo MP (2011) Beneficial effects of quercetin on obesity and diabetes. Open Nutraceuticals J 4:189–198. https://doi.org/10.2174/1876396001104010189

Article  CAS  Google Scholar 

Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ (2022) Type 2 diabetes. Lancet 400:1803–1820. https://doi.org/10.1016/S0140-6736(22)01655-5

Article  PubMed  Google Scholar 

Ahmed OM, Mohamed T, Moustafa H, Hamdy H, Ahmed RR, Aboud E (2018) Quercetin and low-level laser therapy promote wound healing process in diabetic rats via structural reorganization and modulatory effects on inflammation and oxidative stress. Biomed Pharmacother 101:58–73. https://doi.org/10.1016/j.biopha.2018.02.040

Article  CAS  PubMed  Google Scholar 

Ahmed B, Sultana R, Greene MW (2021) Adipose tissue and insulin resistance in obese. Biomed Pharmacother 137:111315. https://doi.org/10.1016/j.biopha.2021.111315

Article  CAS  PubMed  Google Scholar 

Akbari M, Hassan-Zadeh V (2018) IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology 26:685–698. https://doi.org/10.1007/s10787-018-0458-0

Article  CAS  PubMed  Google Scholar 

Alfadul H, Sabico S, Al-Daghri NM (2022) The role of interleukin-1β in type 2 diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 13:901616. https://doi.org/10.3389/fendo.2022.901616

Article  PubMed  Google Scholar 

Ali A, Mounika N, Nath B, Johny E, Kuladhipati I, Das R et al (2024) Platelet-derived sTLT-1 is associated with platelet-mediated inflammation in coronary artery disease patients. Cytokine 178:156581. https://doi.org/10.1016/j.cyto.2024.156581

Article  CAS  PubMed  Google Scholar 

Aliyu M, Zohora FT, Anka AU, Ali K, Maleknia S, Saffarioun M et al (2022) Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach. Int Immunopharmacol 1(111):109130. https://doi.org/10.1016/j.intimp.2022.109130

Article  CAS  Google Scholar 

Alzamil H (2020) Elevated serum TNF-α is related to obesity in type 2 diabetes mellitus and is associated with glycemic control and insulin resistance. J Obes 2020:5076858. https://doi.org/10.1155/2020/5076858

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anand David AV, Arulmoli R, Parasuraman S (2016) Overviews of biological importance of quercetin: a bioactive flavonoid. Pharmacogn Rev 10:84–89. https://doi.org/10.4103/0973-7847.194044

Article  PubMed  PubMed Central  Google Scholar 

Ansari P, Choudhury ST, Seidel V, Rahman AB, Aziz MA, Richi AE et al (2022) Therapeutic potential of quercetin in the management of type-2 diabetes mellitus. Life 12(8):1146. https://doi.org/10.3390/life12081146

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arias N, Macarulla MT, Aguirre L, Martínez-Castaño MG, Portillo MP (2014) Quercetin can reduce insulin resistance without decreasing adipose tissue and skeletal muscle fat accumulation. Genes Nutr 9:361. https://doi.org/10.1007/s12263-013-0361-7

Article  CAS  PubMed  Google Scholar 

Bowker N, Shah RL, Sharp SJ, Luan JA, Stewart ID, Wheeler E et al (2020) Meta-analysis investigating the role of interleukin-6 mediated inflammation in type 2 diabetes. EBioMedicine 1(61):103062. https://doi.org/10.1016/j.ebiom.2020.103062

Article  Google Scholar 

Cheng LJ, Chen JH, Lin MY, Chen LC, Lao CH, Luh H et al (2015) A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients. Sci Rep 5:15687. https://doi.org/10.1038/srep15687

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng SC, Huang WC, S. Pang JH, Wu YH, Cheng CY (2019) Quercetin inhibits the production of IL-1β-induced inflammatory cytokines and chemokines in ARPE-19 cells via the MAPK and NF-κB signaling pathways. Int J Mol Sci 20:2957. https://doi.org/10.3390/ijms20122957

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cho JM, Chang SY, Kim DB, Needs PW, Jo YH, Kim MJ (2012) Effects of physiological quercetin metabolites on interleukin-1β-induced inducible NOS expression. J Nutr Biochem 23(1):1394–1402. https://doi.org/10.1016/j.jnutbio.2011.08.007

Article  CAS  PubMed  Google Scholar 

Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Gálvez J et al (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-κB pathway. Eur J Immunol 35:584–592. https://doi.org/10.1002/eji.200425778

Article  CAS  PubMed  Google Scholar 

Dhanya R (2022) Quercetin for managing type 2 diabetes and its complications, an insight into multitarget therapy. Biomed Pharmacother 146:112560. https://doi.org/10.1016/j.biopha.2021.112560

Article  CAS  PubMed  Google Scholar 

Dokumacioglu E, Iskender H, Sen TM, Ince I, Dokumacioglu A, Kanbay Y et al (2018) The effects of hesperidin and quercetin on serum tumor necrosis factor-alpha and interleukin-6 levels in streptozotocin-induced diabetes model. Pharmacogn Mag 14:167–173. https://doi.org/10.4103/pm.pm_41_17

Article  CAS  PubMed  PubMed Central  Google Scholar 

Domingueti CP, Dusse LM, Carvalho Md, de Sousa LP, Gomes KB, Fernandes AP (2016) Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complications 30:738–745. https://doi.org/10.1016/j.jdiacomp.2015.12.018

Article  PubMed  Google Scholar 

Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98–107. https://doi.org/10.1038/nri2925

Article  CAS  PubMed  Google Scholar 

Dos Santos MG, Arbo BD, Hort MA (2026) Effects of quercetin and its derivatives in in vivo models of neuroinflammation: a systematic review and meta-analysis. Neural Regen Res 21:1783–1792. https://doi.org/10.4103/NRR.NRR-D-24-01175

Article  PubMed  Google Scholar 

Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A et al (2003) Atherosclerosis Risk in Communities Study. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52:1799–1805. https://doi.org/10.2337/diabetes.52.7.1799

Article  CAS  PubMed  Google Scholar 

Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T (2007) Quercetin reduces blood pressure in hypertensive subjects. J Nutr 137:2405–2411. https://doi.org/10.1093/jn/137.11.2405

Article  CAS  PubMed  Google Scholar 

Eitah HE, Maklad YA, Abdelkader NF, El Din AA, Badawi MA, Kenawy SA (2019) Modulating impacts of quercetin/sitagliptin combination on streptozotocin-induced diabetes mellitus in rats. Toxicol Appl Pharmacol 365:30–40. https://doi.org/10.1016/j.taap.2018.12.011

Article  CAS  PubMed  Google Scholar 

Ekor M (2014) The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 4:177. https://doi.org/10.3389/fphar.2013.00177

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eldamarawi M, Abdelazeem M (2020) Effect of quercetin and metformin on glucose transporter-4 expression, oxidative stress, inflammation markers, and insulin resistance in type 2 diabetes mellitus. Bull Egypt Soc Physiol Sci 40:70–85. https://doi.org/10.21608/besps.2020.22519.1041

Article  Google Scholar